Akagi T, Matsumura Y, Ozaki Y, Tsushima T, Obama T, Nasu Y, Ohmori H, Mitsuhata N
Gan To Kagaku Ryoho. 1986 Sep;13(9):2853-5.
Intra-arterial infusion chemotherapy in combination with angiotensin II was performed in 5 patients with advanced bladder cancer (all T3M0). The infusion catheter was inserted from a femoral artery into the internal iliac artery. The basic dosage was 70 mg/m2 of Cis-diammine-dichloroplatinum (CDDP) and 40 mg/m2 of Adriamycin (ADM) or 4'-0-tetrahydropyranyl-ADM (THP) in combination with 20-40 micrograms angiotensin II over a total duration of 20 minutes for both sides. Of the 5 patients, 3 CR and 2 PR were obtained by only one or two courses of intra-arterial infusion chemotherapy. Histological examination showed no viable cells in the three CR cases. Intra-arterial infusion chemotherapy in combination with angiotensin II may thus be clinically useful for advanced bladder cancer.
对5例晚期膀胱癌患者(均为T3M0)实施了动脉内灌注化疗联合血管紧张素II治疗。将灌注导管从股动脉插入髂内动脉。基本剂量为顺二氨二氯铂(CDDP)70mg/m²和阿霉素(ADM)或4'-O-四氢吡喃基-ADM(THP)40mg/m²,同时联合20 - 40微克血管紧张素II,双侧共持续20分钟。5例患者中,仅通过一两个疗程的动脉内灌注化疗就获得了3例完全缓解(CR)和2例部分缓解(PR)。组织学检查显示,3例CR病例中无存活细胞。因此,动脉内灌注化疗联合血管紧张素II在晚期膀胱癌的临床治疗中可能具有应用价值。